Moffitt Researchers Discover Potential New Drug Target to Treat Cutaneous T Cell Lymphoma

Drug that blocks methylation restores SATB1 expression and may be effective against disease

Moffitt Researchers Identify Genomic and Immune Indicators That Predict Lethal Outcomes in High-Grade Prostate Cancer

Together, immune content and Decipher scores can help determine which patients could benefit from targeted therapies

Moffitt Program Bringing Patients, Scientists Together Infuses New Meaning into Research

The Patient Researcher Forum allows patients and researchers to learn from one another

Moffitt Cancer Center’s Dr. Steven Eschrich Named to National Academy of Inventors

The 2020 Fellow class will be inducted in June

Moffitt’s Curbside Clinic Gives Patients Access To Treatment from Their Car

Downtown Tampa Lights Up Teal for Cervical Cancer

Moffitt Cancer Center, World Health Organization bring awareness to global strategy to eliminate disease

Moffitt Researchers Create Chimeric Antigen Receptor Mutations to Enhance CAR T Cell Activity and Survival

Mutations of the CD28 subdomain reduce T cell exhaustion

Dr. Clement Gwede Elected Chair of the Florida Cancer Control Research Advisory Council

Moffitt Cancer Center behavioral scientist will serve a two-year term

Genomic Differences May Be Key to Overcoming Prostate Cancer Disparities Among African American Men

Moffitt Cancer Center researchers say immune response differences could be exploited for personalized treatment options

Moffitt's Chief Compliance Officer Featured in Compliance Today Magazine

Donnetta Horseman contributing regular training tips column

Moffitt Researchers Develop Tool to Better Predict Treatment Course for Lung Cancer Patients

The PET/CT-based deep learning model classifies EGFR mutation status in non-small cell lung cancer, identifying which treatment option is best

Moffitt Researchers Discover Specific Molecules that Promote Cancer Progression

TAp63 regulates long noncoding RNA molecules that promote tumor development by activating AKT

Moffitt Cancer Center a Digital Health Most Wired Organization for 2nd Year in a Row

Moffitt Cancer Center was recently named one of HealthCare’s Most Wired organizations for 2020 by the College of Healthcare Information Management...

Moffitt Cancer Center and AdventHealth Announce Next Step in Research Partnership

Steven R. Smith, M.D., appointed to oversee and build collaboration, with goal of achieving National Cancer Institute Consortium status

Virtual Miles for Moffitt Oct. 24 Lets You Pound the Pavement Anywhere

100% of registrations and donations will support vital cancer research

News Releases